Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
KETAMINE
Neurology & Sedation · Neurology & Sedation · Level 1
|
Midazolam
Neurology & Sedation · Neurology & Sedation · Level 1
|
|---|---|---|
| Mechanism of action | NMDA receptor antagonism |
increases the sensitivity GABAA receptors which open (via GABA) and allow Cl influx |
| Physiological effects | CNS: Causes dissociative anaesthesia CVS: Indirect sympathomimetic |
CNS: Sedative, reduces epileptiform activity, Resp: respiratory depression - synergistic with opioids |
| Absorption | A: 20% oral bioavailability |
A : IV,PO,In,IM |
| Distribution | — | lipid soluble at physiological pH (pKa 6.5). |
| Protein binding | 25% |
Approximately 96% protein-bound in plasma. Neurology & Sedation · Neurology & Sedation highly protein bound (95%) Neurology & Sedation · Neurology & Sedation 95% |
| Volume of distribution | 3l/kg |
Volume of distribution approximately 0.8-1.5 L/kg, increasing to about 3.1 L/kg in critically ill patients. Neurology & Sedation · Neurology & Sedation small-mod Vd = 1-2 L/kg Neurology & Sedation · Neurology & Sedation 1-2 L/kg |
| Metabolism | Hepatic metabolism with active |
hepatic via CYP3A4, and glucuronidation |
| Excretion | Renal elimination |
excreted in urine (as glucuronide conjugated metabolites) |
| Half-life | T1/2a 15 mins, T1/2b |
half life 1-4 hrs |
| Adverse Effects Toxicity | Increased salivation - Upper airway reflexes intact laryngospasm - Hypotension if given in shock states - Emergence delirium |
Respiratory depression and excessive sedation with overdosage Neurology & Sedation · Neurology & Sedation Respiratory depression and excessive sedation with overdosage |
| Chemical Pharmaceutics | — | - Imidazole ring in its structure - Accounts for water solubility And rapid metabolism |
| Class Group | Sedative/hypnotic with non-opioid analgesic properties. Non-Opiate Analgesic Neurology & Sedation · Neurology & Sedation Sedative / Hypnotic |
Anticonvulsant Sedative-Hypnotic Neurology & Sedation · Neurology & Sedation Anticonvulsant Neurology & Sedation · Neurology & Sedation Sedative / Hypnotic |
| Indications Uses | Induction of anaesthesia |
Sedative, amnesic+ anxiolytic, |
| Introduction | Phencyclidine (remember the street drug name PCP) derivative that |
- Benzodiazepine |
| Legacy Cicm Level | Level 1 |
Level 1 |
| Presentation | 10, 50 or 100mg/ml |
Clear solution pH 3.5 (IV/IM), Tablet |
| Route And Dose | - 1mg/kg induction dose |
2-2.5mg initially then 1mg boluses to eff¬ect |